Company · CIK 0001799788 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Greenwich LifeSciences, Inc. · GLSI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 PForm 4 → | Jul 30, 6:05 am EDT | Snehal PatelCEO and CFO, Director, 10% Owner | 2,200 | $13.43 | $29,555 | 5,611,402 | +0.04% | |
| Jul 27, 2026 PForm 4 → | Jul 29, 6:05 am EDT | Snehal PatelCEO and CFO, Director, 10% Owner | 1,500 | $13.62 | $20,430 | 5,609,202 | +0.03% | |
| Jul 23, 2026 PForm 4 → | Jul 27, 6:15 am EDT | Snehal PatelCEO and CFO, Director, 10% Owner | 3,600 | $13.06 | $47,018 | 5,607,702 | +0.06% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.